We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 3,577 results
  1. Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease

    Microbial transformation of bile acids affects intestinal immune homoeostasis but its impact on inflammatory pathologies remains largely unknown....

    Sarah Lindner, Oriana Miltiadous, ... Marcel R. M. van den Brink in Nature Microbiology
    Article 01 March 2024
  2. Tetramerization of pyruvate kinase M2 attenuates graft-versus-host disease by inhibition of Th1 and Th17 differentiation

    Lethal graft-versus-host disease (GVHD) is the major complication of allogeneic hematopoietic stem-cell transplantation (Allo-HSCT). Pyruvate kinase...

    Meng Wang, Qiu-Jie Li, ... **g-Lan Zhang in Human Cell
    Article 28 February 2024
  3. Glucocorticoid and glycolysis inhibitors cooperatively abrogate acute graft-versus-host disease

    Although glucorticosteroids (GCs) are the standard first-line therapy for acute graft-versus-host disease (aGvHD), nearly 50% of aGvHD patients have...

    Qi Wen, Zheng-Li Xu, ... Yuan Kong in Science China Life Sciences
    Article 22 September 2022
  4. The Role of NK Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia

    Natural killer (NK) cells are one of the innate immune cells that play an important role in preventing and controlling tumors and viral diseases, but...

    Alireza Zafarani, Mahsa Taghavi-Farahabadi, ... Mohammad Mahmoudi in Stem Cell Reviews and Reports
    Article 22 August 2022
  5. Immune Checkpoints and targeted agents in relapse and graft-versus-host disease after hematopoietic stem cell transplantation

    Background:

    Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative therapy for malignant hematologic disorders. Novel...

    **** Zhu, Jia Chen in Molecular Biology Reports
    Article 26 December 2022
  6. Inflammasome activation occurs in CD4+ and CD8+ T cells during graft-versus-host disease

    A severe complication of hematopoietic stem cell transplantation is graft-versus-host disease (GvHD), a reaction that occurs following the transfer...

    Sarah Talley, David J. Rademacher, Edward M. Campbell in Cell Death & Disease
    Article Open access 25 September 2023
  7. Adipose tissue-derived human mesenchymal stromal cells can better suppress complement lysis, engraft and inhibit acute graft-versus-host disease in mice

    Background

    Acute graft-versus-host disease (aGvHD) is a life-threatening complication of allogeneic hematopoietic stem cell transplantation (HSCT)....

    Stanley Chun Ming Wu, Manyu Zhu, ... Ellen Ngar-Yun Poon in Stem Cell Research & Therapy
    Article Open access 25 June 2023
  8. Humanized Mouse Model to Study the P2X7 Receptor in Graft-Versus-Host Disease

    Humanized mouse models of graft-versus-host disease (GVHD), where human immune cells are injected into immune deficient mice, are well established...
    Debbie Watson, Sam R. Adhikary, ... Ronald Sluyter in The P2X7 Receptor
    Protocol 2022
  9. The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study

    This study reports the incidence of chronic graft versus host disease (GvHD) in allogeneic hematopoietic stem cell transplant (alloHCT) recipients...

    Dat Ngo, Jason Chen, ... Haris Ali in Stem Cell Research & Therapy
    Article Open access 18 April 2023
  10. Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases—systemic sclerosis and sclerodermatous graft-versus-host disease

    Background

    Systemic sclerosis (SSc) and sclerodermatous graft-versus-host disease (Scl-GVHD)—characterized by similar developmental fibrosis, vascular...

    Han Yang, Sousan Cheong, ... Feng Lu in Stem Cell Research & Therapy
    Article Open access 18 December 2023
  11. Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review

    Background

    Graft-versus-host disease (GVHD) is a common fatal complication of hematopoietic stem cell transplantation (HSCT), where steroids are used...

    Ying Li, Jie Hao, ... Jun Wu in Stem Cell Research & Therapy
    Article Open access 04 March 2022
  12. MiR-181a and -b expression in acute lymphoblastic leukemia and its correlation with acute graft-versus-host disease after hematopoietic stem cell transplantation, COVID-19 and torque teno viruses

    Acute lymphoblastic leukemia (ALL), a malignant transformation and proliferation of the lymphoid line of blood cells, is characterized by chromosomal...

    Mahdiyar Iravani Saadi, Mani Ramzi, ... Zahed Karimi in VirusDisease
    Article 25 October 2021
  13. Cyclosporine A and IFNγ licencing enhances human mesenchymal stromal cell potency in a humanised mouse model of acute graft versus host disease

    Immunosuppressive ability in human MSC donors has been shown to be variable and may be a limiting factor in MSC therapeutic efficacy in vivo. The...

    Jennifer M. Corbett, Ian Hawthorne, ... Karen English in Stem Cell Research & Therapy
    Article Open access 14 April 2021
  14. Wnt/β-catenin signaling mediates the abnormal osteogenic and adipogenic capabilities of bone marrow mesenchymal stem cells from chronic graft-versus-host disease patients

    Chronic graft-versus-host disease (cGVHD) is the main cause of non-relapse mortality after allogeneic hematopoietic stem cell transplantation...

    Han-zhou Qi, Yi-ling Ye, ... Qi-fa Liu in Cell Death & Disease
    Article Open access 23 March 2021
  15. Tear proteomic profile in three distinct ocular surface diseases: keratoconus, pterygium, and dry eye related to graft-versus-host disease

    Background

    Diseases of the anterior segment of the eye may present different mechanisms, intensity of symptoms, and impact on the patients’ quality of...

    Daniel de Almeida Borges, Marcos Rodrigo Alborghetti, ... Monica Alves in Clinical Proteomics
    Article Open access 07 December 2020
  16. Arsenic trioxide alleviates acute graft-versus-host disease by modulating macrophage polarization

    This study aimed to explore macrophage polarization in acute graft-versus-host disease after hematopoietic stem cell transplantation, and...

    **ao Liu, Yan Su, ... **aohui Zhang in Science China Life Sciences
    Article 06 May 2020
  17. Graft failure after allogeneic hematopoietic stem cell transplantation in pediatric patients with acute leukemia: autologous reconstitution or second transplant?

    Background

    Graft failure (GF) is a rare but serious complication after allogeneic hematopoietic stem cell transplantation (HSCT). Prevention of graft...

    Tahereh Rostami, Mohammad Reza Rostami, ... Amir Kasaeian in Stem Cell Research & Therapy
    Article Open access 22 April 2024
  18. Preclinical Studies of MSC-Derived Extracellular Vesicles to Treat or Prevent Graft Versus Host Disease: a Systematic Review of the Literature

    Introduction

    Treating and preventing graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplant (HCT) remains a significant...

    Manika Gupta, Alvin Tieu, ... David S. Allan in Stem Cell Reviews and Reports
    Article 07 November 2020
  19. Mesenchymal stromal cells as prophylaxis for graft-versus-host disease in haplo-identical hematopoietic stem cell transplantation recipients with severe aplastic anemia?—a systematic review and meta-analysis

    Background

    Mesenchymal stromal cells (MSCs) are an emerging prophylaxis option for graft-versus-host disease (GVHD) in haplo-identical hematopoietic...

    Ruonan Li, **gke Tu, ... Jun Shi in Stem Cell Research & Therapy
    Article Open access 04 February 2021
Did you find what you were looking for? Share feedback.